Q2 2015

Filed Aug 13, 2015 · 10-Q · 44 days after period end · 0001121781-15-000224

Q2 2015 · 10-Q

Revenue

$10.00K

−9.1% vs Q2 2014

Net Income

-$1.71M

N/M vs Q2 2014

EPS Diluted

-$0.03

N/M vs Q2 2014

Gross Profit-$104,000N/M

Operating Income

Same quarter

Metric	Q2 2015	Q2 2014	Q2 2013	Q2 2012
Revenue	$10.00K	$11.00K	$222.00K	$915.00K
Net Income	-$1.71M	-$2.15M	-$1.75M	-$1.17M
EPS Diluted	-$0.03	-$0.03	-$0.04	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR